NovoEight IV 1000 (YJ code: 6343440D3026, 1,000 IU x 1 bottle (with dissolving liquid)), manufactured by Novo Nordisk Pharma, contains Turoctocog alpha (genetically recombination). This recombinant Factor VIII is approved for the treatment and prevention of bleeding in patients with hemophilia A.
NovoEight IV 1000
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →